ArticleSchizophrenia bulletin2026
Vocal Markers of Schizophrenia: Assessing the Generalizability of Machine Learning Models and Their Clinical Applicability.
Article in Schizophrenia bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Validating objective and scalable speech markers of depression across two independent psychiatric cohorts.Annals of general psychiatry · 2026Article
- Reading between the lines: Combining pause dynamics and semantic coherence for automated assessment of thought disorder.Neuropsychologia · 2026Article
- Screening for depression risk via smartphone narratives with fully fine-tuned WavLM.Scientific reports · 2026Article
- Voice as a digital biomarker in schizophrenia: a scoping review protocol on the application of artificial intelligence.BMJ open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
background and hypothesisMachine learning (ML) models have been argued to reliably predict diagnosis and symptoms of schizophrenia based on voice data only. However, it is unclear to what extent such ML markers would generalize to different clinical samples and different languages, a crucial assessment to move toward clinical applicability. In this study, we systematically assessed the generalizability of current ML models of vocal markers of schizophrenia across contexts and languages. STUDY
designWe trained models relying on a large cross-linguistic dataset (Danish, German, Chinese) of 217 patients with schizophrenia and 221 controls, and used a conservative pipeline to minimize overfitting. We tested the models' generalizability on: (Q1) new participants, speaking the same language; (Q2) new participants, speaking a different language; (Q3-Q4) further, we assessed whether training on data with multiple languages would improve generalizability using Mixture of Expert (MoE) and multilingual models.
resultsModel performance was comparable to state-of-the-art findings (F1-score ~0.75) within the same language; however, models did not generalize well-showing a substantial decrease-when tested on new languages. The performance of MoE and multilingual models was generally low (F1-score ~0.50).
conclusionsOverall, the cross-linguistic generalizability of vocal markers of schizophrenia is limited. We argue that more emphasis should be placed on collecting large open cross-linguistic datasets to systematically test the generalizability of voice-based ML models, and on identifying more precise mechanisms of how the clinical features of schizophrenia are expressed in language and voice, and how different languages vary in that expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.